Skip to content

6 minute read

How to Get Retatrutide Online in Szczecin

Written by Hi Doctor editorial teamPublished 23 April 2026

Retatrutide is an experimental weight-loss treatment currently in clinical trials and not yet approved for prescription in the EU. This means it is not legally available in Szczecin, Poland, or anywhere in the European Union.

How to Get Retatrutide Online in Szczecin, article cover image
Share:

DIRECT ANSWER

An online consultation lets an EU-licensed doctor review your case and, if appropriate, issue a prescription that is valid across the EU.

Doctor reply in under 2 hours

Average doctor reply under 2 hours; prescription within 24 hours if approved.

EU-licensed doctors

Every case is reviewed by a licensed clinician.

Valid across the EU

Approved prescriptions can be used at any EU pharmacy.

Many individuals in Szczecin, Poland, and across the EU are exploring advanced options for weight management, and medications like Retatrutide often come up in searches. However, it's crucial to understand that Retatrutide is currently not approved for weight-loss prescription in the EU and is still undergoing clinical trials. Consequently, Hi-Doctor does not currently offer or prescribe Retatrutide. Here's what Retatrutide actually is, why it isn't a standard option yet, and what proven, EU-approved weight-loss treatments you CAN get today from an EU-licensed doctor.

What is Retatrutide, and why isn't it a normal option yet?

Retatrutide is an investigational drug developed for the treatment of obesity and type 2 diabetes. It functions as a triple agonist, targeting three key gut hormone receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon. This multi-pathway approach has shown promising results in early-stage clinical trials, leading to significant weight loss. However, promising trial results do not equate to market availability. The European Medicines Agency (EMA) and other regulatory bodies require extensive, multi-phase clinical trials to establish long-term safety and efficacy before granting approval. Retatrutide is still in these trial phases, meaning it has not yet completed the rigorous review process required for prescription use in the EU. Purchasing unapproved substances online from unregulated sources, often marketed as 'research chemicals' or grey-market peptides, carries significant health risks, including unknown purity, dosage, and potential for severe side effects without medical oversight.

Proven weight-loss medications available online today

While Retatrutide is not yet available, several highly effective, EU-approved medications are prescribed by doctors for weight management. These treatments have undergone stringent regulatory review and offer a safe, medically supervised path to weight loss:

  • Ozempic (semaglutide): A GLP-1 receptor agonist, approved for type 2 diabetes but often prescribed off-label for weight management by EU-licensed doctors when clinically appropriate.
  • Wegovy (semaglutide): The same active ingredient as Ozempic but at higher doses, specifically approved and indicated for chronic weight management in adults with obesity or overweight with comorbidities.
  • Mounjaro (tirzepatide): A dual GIP and GLP-1 receptor agonist, approved for type 2 diabetes and recently for weight management, offering significant weight loss benefits under medical supervision.
  • Saxenda (liraglutide): A daily GLP-1 receptor agonist, approved for chronic weight management, suitable for individuals seeking a proven injectable option.

How to get a weight-loss prescription online in Szczecin, Poland

Hi-Doctor provides a straightforward, safe, and fully compliant process to access approved weight-loss medications like those listed above from Szczecin or anywhere in the EU. Our service connects you with EU-licensed doctors for a confidential medical review:

  1. Complete Online Questionnaire: Fill out a comprehensive medical questionnaire (takes 2–3 minutes) about your health, medical history, and weight-loss goals.
  2. Doctor Reviews Your Case: An EU-licensed doctor reviews your information. This individual case review ensures the treatment is safe and appropriate for your specific health profile.
  3. Receive Electronic Prescription: If the doctor approves treatment, an electronic prescription (Spanish standard, valid EU-wide) is issued within 24 hours. This is delivered as a downloadable PDF in your secure patient account and via email. The consultation fee is 25 € every 28 days (cancel anytime) or 35 € one-off, fully refunded if treatment is not appropriate.
  4. Pick Up at Any EU Pharmacy: Present your digital prescription at ANY pharmacy in any EU country, including those in Szczecin, Poland, under the cross-border prescription directive 2011/24/EU.

Why choose Hi-Doctor over unregulated peptide sellers

When considering weight-loss treatments, safety and legitimacy should be paramount. Choosing Hi-Doctor ensures you receive genuine, medically approved medications under the care of EU-licensed professionals, a stark contrast to the risks associated with unregulated sources:

  • EU-Licensed Doctors: All consultations and prescriptions are handled by qualified, licensed medical practitioners operating within EU regulations.
  • Real Medications, Real Pharmacies: Prescriptions are for legitimate, pharmaceutical-grade medications available at any EU pharmacy, ensuring product quality and traceability.
  • Auditable & Compliant Care: All communication and records are secured within your private, RGPD-compliant patient account, ensuring privacy and accountability.
  • Trusted & Experienced: With over 50,000 patients served and a 4.8 Trustpilot rating, Hi-Doctor is a reputable and reliable platform for online medical care.
  • No Risk Consultation: The consultation fee of €25 every 28 days or €35 one-off is fully refundable if our doctor determines that treatment is not suitable for you.

COMMON QUESTIONS

Frequently asked questions

No, Retatrutide is not legally available for purchase online or in pharmacies in Poland or any other EU country. It is an experimental drug not yet approved by the European Medicines Agency (EMA).

Dr. Alejandro Infante
General medicine · Reg. 080869277

Own your health

Doctor-reviewed guides and new treatments. At most two emails a month.

All content on this page has been medically reviewed by: Dr. Alejandro Infante, General medicine, on 27 July 2026. Registration: 080869277 View profile

Pay nothing if a doctor doesn't approve your treatment. Every consultation is fully refundable. How refunds work